GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,000 | +100.0% | 10 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 10 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $2,000 | 0.0% | 10 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $2,000 | +100.0% | 10 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -80.0% | 10 | -80.0% | 0.00% | -100.0% |
| Q2 2017 | $5,000 | -16.7% | 50 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $6,000 | 0.0% | 50 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $6,000 | -14.3% | 50 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $7,000 | +40.0% | 50 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $5,000 | +25.0% | 50 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $4,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |